It appears that we are now looking more and more at diabetes as a cardiovascular risk factor, and our therapies and goals for diabetes care need to be targeted in that direction. In order to help make this message as clear as possible, we have focused our homerun slides and our exclusive interview on this concept.
Our Diabetes for Cardiologists slides look at the use of Sulfonylureas in heart patients and the cardiovascular risks associated, while our Exclusive Interview has our publisher, Steve Freed, in discussion with Dr. Aaron Vinik about this new concept of “treating for cardiovascular outcomes.”
As a special bonus Dr. Vinik discusses how current INGAP research may change how we treat diabetes patients for many years to come.
Your partner in diabetes care,